by healthadvances Posted on June 24, 2022June 24, 2022 From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology Read More
by healthadvances Posted on May 4, 2022 Digital Health in Japan and Korea – Where Is It Heading? Read More
by healthadvances Posted on February 25, 2022 Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases Read More
by healthadvances Posted on February 15, 2022 Women’s Health at Home: Reflections on a Rapidly Growing Space Read More
by healthadvances Posted on October 8, 2021 Building and Defending Markets; Reflections on Attending DTx and NASS Conferences Read More
by healthadvances Posted on October 1, 2021October 1, 2021 Resurgence in Drug Development for Renal Diseases Read More
by healthadvances Posted on September 29, 2021October 1, 2021 AI in Healthcare: Insights from Two Decades of FDA Approvals Read More
by healthadvances Posted on August 6, 2021August 9, 2021 Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better? Read More
by healthadvances Posted on April 24, 2020 The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed? Read More
by healthadvances Posted on February 28, 2020April 13, 2020 Overcoming Challenges to Realize the Promise of Genetic Medicine Read More
by healthadvances Posted on February 27, 2020April 13, 2020 Reflecting on the 17th Annual HBS Healthcare Conference Read More